Article info

Download PDFPDF

Correspondence
Monocyte type I interferon signature in antiphospholipid syndrome is related to proinflammatory monocyte subsets, hydroxychloroquine and statin use
Free

Authors

  • Lucas L van den Hoogen Laboratory of Translational Immunology, University Medical Centre Utrecht, Utrecht, The Netherlands Department of Rheumatology and Clinical Immunology, University Medical Centre Utrecht, Utrecht, The Netherlands PubMed articlesGoogle scholar articles
  • Ruth D E Fritsch-Stork Department of Rheumatology and Clinical Immunology, University Medical Centre Utrecht, Utrecht, The Netherlands 1st Medical Department Hanusch Hospital, Ludwig Boltzmann Institute of Osteology at the Hanusch Hospital of WGKK and AUVA Trauma Centre Meidling, Vienna, Austria Sigmund Freud University, Vienna, Austria PubMed articlesGoogle scholar articles
  • Marjan A Versnel Department of Immunology, Erasmus Medical Centre, Rotterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Ronald H WM Derksen Department of Rheumatology and Clinical Immunology, University Medical Centre Utrecht, Utrecht, The Netherlands PubMed articlesGoogle scholar articles
  • Joël A G van Roon Laboratory of Translational Immunology, University Medical Centre Utrecht, Utrecht, The Netherlands Department of Rheumatology and Clinical Immunology, University Medical Centre Utrecht, Utrecht, The Netherlands PubMed articlesGoogle scholar articles
  • Timothy R DJ Radstake Laboratory of Translational Immunology, University Medical Centre Utrecht, Utrecht, The Netherlands Department of Rheumatology and Clinical Immunology, University Medical Centre Utrecht, Utrecht, The Netherlands PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Lucas L van den Hoogen, University Medical Centre Utrecht, Laboratory of Translational Immunology, KC.02.085.2, Lundlaan 6, Utrecht 3584 GA, The Netherlands; l.l.vandenhoogen{at}umcutrecht.nl
View Full Text

Citation

van den Hoogen LL, Fritsch-Stork RDE, Versnel MA, et al
Monocyte type I interferon signature in antiphospholipid syndrome is related to proinflammatory monocyte subsets, hydroxychloroquine and statin use

Publication history

  • Received September 7, 2016
  • Accepted September 13, 2016
  • First published September 28, 2016.
Online issue publication 
November 10, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.